The Fidelity MSCI Health Care Index ETF (FHLC) has an implied analyst target price of $76.70 per unit, indicating a potential upside of 21.19% from its current trading price of $63.29. This analysis was conducted by ETF Channel, which compared the ETF’s holdings against average analyst 12-month forward target prices.
Among FHLC’s significant holdings, Bioventus Inc (BVS) shows a potential upside of 92.10%, with a recent price of $6.42 compared to an average target of $12.33. BioCryst Pharmaceuticals Inc (BCRX) has a 65.66% upside, trading at $9.96 against a target of $16.50, and ArriVent Biopharma Inc (AVBP) is priced at $24.89 with a target of $39.50, reflecting a 58.70% upside.
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| Fidelity MSCI Health Care Index ETF | FHLC | $63.29 | $76.70 | 21.19% |
| Bioventus Inc | BVS | $6.42 | $12.33 | 92.10% |
| BioCryst Pharmaceuticals Inc | BCRX | $9.96 | $16.50 | 65.66% |
| ArriVent Biopharma Inc | AVBP | $24.89 | $39.50 | 58.70% |
